Therapeutic errors involving diabetes medications reported to United States poison centers.

ABSTRACT:

Background

To investigate the characteristics and trends of therapeutic errors that occur outside of healthcare facilities involving diabetes medications reported to US poison centers.

Methods

National Poison Data System data from 2000 to 2021 were retrospectively analyzed.

Results

There were 157,623 exposure cases of non-healthcare facility-related therapeutic errors associated with diabetes medications as the primary substance reported to US poison centers from 2000 to 2021. The rate of all therapeutic errors involving diabetes medications increased by 279.8% from 2000 to 2011, followed by a slower 15.0% increase to 2021. Half (50.1%) of the exposure cases were treated/evaluated and released and 44.1% did not receive treatment in a healthcare facility; however, 9.9%

SUBMITTER: Thurgood Giarman A 

PROVIDER: S-EPMC11412010 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature